🕵️ Crinetics Pharmaceuticals, Inc. ($CRNX)
SEC insider & ownership activity, last 12 months · CIK 1658247 · every row links its SEC filing
Over the last 12 months insiders sold $8.9M with no open-market buying against it. Jeff Knight sold $3.8M through a 10b5-1 trading plan in 3 lots (Mar–Apr). 2 planned sales are pending, the largest $1.8M (Jeff Knight). No red-flag 8-Ks in the window.
🚨 6 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $8.9M (24 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jeff Knight | 0 | – | 3 | $3.8M | Apr 8, 2026 |
| Dana Pizzuti | 0 | – | 7 | $1.9M | Dec 1, 2025 |
| Struthers Richard Scott | 0 | – | 3 | $1.0M | Mar 16, 2026 |
| Matthew K. Fust | 0 | – | 1 | $716K | Sep 26, 2025 |
| Stephen Betz | 0 | – | 2 | $397K | Mar 16, 2026 |
| Stephanie Okey | 0 | – | 3 | $365K | Jun 17, 2026 |
| Rogerio Vivaldi Coelho | 0 | – | 3 | $301K | Jul 2, 2026 |
| Tobin Schilke | 0 | – | 1 | $266K | Mar 3, 2026 |
| Isabel Kalofonos | 0 | – | 1 | $138K | Jan 5, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 15.0% | 13G | May 12, 2025 | filing ↗ | |
| Abigail P. Johnson | 15.0% | 13G | May 12, 2025 | filing ↗ | |
| Joshua J. Dapice | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Dreyfuss, Philip D. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Hannah E. Dunn | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Gehani, Varun N. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Giauque, Nicolas | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Husen, Avner A. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| KIM, David T. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| LINN, Michael G. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| LUO Patrick (CHENG) | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Roberts, JR., Thomas G. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Edric C. Saito | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Daniel S. Short | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Spokes, Andrew J. M. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Warren, JOHN R. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Wehrly, MARK C. | 8.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Farallon Partners, L.L.C. | 8.2% | 13G | Feb 5, 2026 | filing ↗ | |
| Wellington Management Group LLP | 7.8% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Group Holdings LLP | 7.8% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Investment Advisors Holdings LLP | 7.8% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Management Company LLP | 7.4% | 13G | May 15, 2026 | filing ↗ | |
| Driehaus Capital Management LLC | 6.1% | 13G | May 15, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing ↗ | |
| T. ROWE Price Associates, Inc. | 5.1% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Jeff Knight | $1.8M | Jul 2, 2026 | filing ↗ |
| Rogerio Vivaldi Coelho | $232K | Jul 2, 2026 | filing ↗ |
| Stephanie Okey | $242K | Jun 17, 2026 | filing ↗ |
| Jeff Knight | $370K | May 4, 2026 | filing ↗ |
| Jeff Knight | $808K | Apr 14, 2026 | filing ↗ |
| Jeff Knight | $175K | Apr 13, 2026 | filing ↗ |
| Jeff Knight | $3.3M | Apr 8, 2026 | filing ↗ |
| Dana Pizzuti | $938K | Mar 18, 2026 | filing ↗ |
| Jeff Knight | $941K | Mar 16, 2026 | filing ↗ |
| Stephen Betz | $994K | Mar 16, 2026 | filing ↗ |
| Richard Scott Struthers | $1.7M | Mar 16, 2026 | filing ↗ |
| Rogerio Vivaldi Coelho | $185K | Mar 12, 2026 | filing ↗ |
| Stephanie S Okey | $122K | Mar 3, 2026 | filing ↗ |
| Tobin Schilke | $280K | Mar 2, 2026 | filing ↗ |
| Dana Pizzuti | $499K | Feb 2, 2026 | filing ↗ |
| Isabel Kalofonos | $117K | Jan 5, 2026 | filing ↗ |
| Dana Pizzuti | $233K | Jan 2, 2026 | filing ↗ |
| Dana Pizzuti | $228K | Dec 1, 2025 | filing ↗ |
| Dana Pizzuti | $218K | Nov 3, 2025 | filing ↗ |
| Dana Pizzuti | $208K | Oct 1, 2025 | filing ↗ |
| Struthers Richard Scott | $180K | Sep 26, 2025 | filing ↗ |
| Matthew K Fust | $574K | Sep 26, 2025 | filing ↗ |
| Dana Pizzuti | $155K | Sep 2, 2025 | filing ↗ |
| Dana Pizzuti | $882K | Aug 22, 2025 | filing ↗ |
| Dana Pizzuti | $191K | Aug 20, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 6, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 6, 2026 | filing ↗ |
| Other events (8.01) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 17, 2026 | filing ↗ |
| Auditor change (4.01) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Earnings (2.02) | Jan 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 5, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |